Φορτώνει......
Targeting development of incretin-producing cells increases insulin secretion
Glucagon-like peptide-1–based (GLP-1–based) therapies improve glycemic control in patients with type 2 diabetes. While these agents augment insulin secretion, they do not mimic the physiological meal-related rise and fall of GLP-1 concentrations. Here, we tested the hypothesis that increasing the nu...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Clin Invest |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Society for Clinical Investigation
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382243/ https://ncbi.nlm.nih.gov/pubmed/25500886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI75838 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|